Infectious Disease Diagnostic Testing Market Report – Research, Industry Analysis Reports and Market Demands

Global Infectious Disease Diagnostic Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Infectious Disease Diagnostic Testing Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Infectious Disease Diagnostic Testing by Company Revenue
- 3.2.2 Top 3 Infectious Disease Diagnostic Testing Players Market Share in 2025
- 3.2.3 Top 6 Infectious Disease Diagnostic Testing Players Market Share in 2025
3.3 Infectious Disease Diagnostic Testing Market: Overall Company Footprint Analysis
- 3.3.1 Infectious Disease Diagnostic Testing Market: Region Footprint
- 3.3.2 Infectious Disease Diagnostic Testing Market: Company Product Type Footprint
- 3.3.3 Infectious Disease Diagnostic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Infectious Disease Diagnostic Testing Consumption Value and Market Share by Type (2021-2026)
4.2 Global Infectious Disease Diagnostic Testing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Infectious Disease Diagnostic Testing Consumption Value Market Share by Application (2021-2026)
5.2 Global Infectious Disease Diagnostic Testing Market Forecast by Application (2027-2032)

6 North America

6.1 North America Infectious Disease Diagnostic Testing Consumption Value by Type (2021-2032)
6.2 North America Infectious Disease Diagnostic Testing Market Size by Application (2021-2032)
6.3 North America Infectious Disease Diagnostic Testing Market Size by Country
- 6.3.1 North America Infectious Disease Diagnostic Testing Consumption Value by Country (2021-2032)
- 6.3.2 United States Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 6.3.3 Canada Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Infectious Disease Diagnostic Testing Consumption Value by Type (2021-2032)
7.2 Europe Infectious Disease Diagnostic Testing Consumption Value by Application (2021-2032)
7.3 Europe Infectious Disease Diagnostic Testing Market Size by Country
- 7.3.1 Europe Infectious Disease Diagnostic Testing Consumption Value by Country (2021-2032)
- 7.3.2 Germany Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 7.3.3 France Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 7.3.5 Russia Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 7.3.6 Italy Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Infectious Disease Diagnostic Testing Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Infectious Disease Diagnostic Testing Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Infectious Disease Diagnostic Testing Market Size by Region
- 8.3.1 Asia-Pacific Infectious Disease Diagnostic Testing Consumption Value by Region (2021-2032)
- 8.3.2 China Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 8.3.3 Japan Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 8.3.5 India Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 8.3.7 Australia Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)

9 South America

9.1 South America Infectious Disease Diagnostic Testing Consumption Value by Type (2021-2032)
9.2 South America Infectious Disease Diagnostic Testing Consumption Value by Application (2021-2032)
9.3 South America Infectious Disease Diagnostic Testing Market Size by Country
- 9.3.1 South America Infectious Disease Diagnostic Testing Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Infectious Disease Diagnostic Testing Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Infectious Disease Diagnostic Testing Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Country
- 10.3.1 Middle East & Africa Infectious Disease Diagnostic Testing Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)
- 10.3.4 UAE Infectious Disease Diagnostic Testing Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Infectious Disease Diagnostic Testing Market Drivers
11.2 Infectious Disease Diagnostic Testing Market Restraints
11.3 Infectious Disease Diagnostic Testing Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Infectious Disease Diagnostic Testing Industry Chain
12.2 Infectious Disease Diagnostic Testing Upstream Analysis
12.3 Infectious Disease Diagnostic Testing Midstream Analysis
12.4 Infectious Disease Diagnostic Testing Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Infectious Disease Diagnostic Testing market size was valued at US$ 26692 million in 2025 and is forecast to a readjusted size of US$ 36133 million by 2032 with a CAGR of 4.5% during review period.
Infectious Disease Diagnostic Testing refers to a product and method system used to detect infections caused by viruses, bacteria, fungi, parasites, mycoplasma, chlamydia, and other pathogens. It uses in-vitro diagnostic reagents, testing instruments, automated platforms, point-of-care devices, quality-control systems, and informatics tools to analyze human samples such as blood, respiratory specimens, urine, stool, cerebrospinal fluid, secretions, and tissue. Targets may include pathogen nucleic acids, antigens, antibodies, toxins, resistance genes, culture results, or host immune-response markers. The field covers molecular testing, immunoassays, microbiological culture, mass spectrometry identification, antimicrobial susceptibility testing, multiplex panels, sequencing, and POCT rapid testing. It serves clinical diagnosis, medication guidance, infection control, disease screening, public health surveillance, border quarantine, and epidemic early warning, forming a critical capability for early detection, early diagnosis, early treatment, and precise prevention.The average gross profit margin of this product is 53%.
Infectious disease diagnostic testing is evolving from single-outbreak emergency testing into a long-term demand-driven market supported by clinical care, public health surveillance, infection control, and antimicrobial stewardship. Respiratory infections, blood-borne diseases, gastrointestinal infections, sexually transmitted infections, tuberculosis, antimicrobial-resistant pathogens, and emerging infectious diseases all require healthcare and public health systems to build rapid, accurate, and traceable testing capabilities. Governments continue to strengthen infectious disease surveillance and early warning, laboratory capacity, medical-public health coordination, and interconnection of testing data, providing a stable institutional environment for the industry. Corporate annual reports show that global diagnostic leaders are continuously investing in molecular diagnostics, rapid testing, microbiology, and multiplex panels, driving the industry from single assays toward platform-based, automated, and data-driven testing.The industry faces multiple challenges, including demand volatility, pricing pressure, regulatory access, technology iteration, quality consistency, and product homogenization. After the pandemic, demand for some single-pathogen tests has returned to a more normalized level, requiring companies to shift from short-cycle outbreak-driven products toward comprehensive portfolios covering multiple diseases, sample types, and clinical scenarios. Molecular testing requires high sensitivity, specificity, contamination control, and robust laboratory workflows. Immunoassays depend on antigen and antibody quality, lot-to-lot consistency, and signal stability. Microbiological testing is strongly affected by sample processing, culture identification, antimicrobial susceptibility interpretation, and database accumulation. At the same time, public health demand can be sudden and seasonal, requiring stronger resilience in capacity planning, inventory management, raw-material supply, and channel response. Future competition will shift from price to clinical value, platform compatibility, test-menu completeness, and supply-chain security.Downstream demand is moving from “whether a test is available” to “whether testing can be faster, more accurate, and more closely linked to clinical decisions.” Emergency departments, infectious disease departments, respiratory departments, intensive care units, clinical laboratories, and infection-control teams in large hospitals need rapid etiological testing, resistance monitoring, and multiplex panels to shorten diagnostic time, optimize medication pathways, and reduce nosocomial transmission risk. Primary healthcare institutions need rapid testing solutions that are easy to operate, short in turnaround time, and suitable for initial screening and triage. Independent clinical laboratories focus on batch testing, automated workflows, and cost efficiency, while public health systems value pathogen-spectrum monitoring, regional epidemic assessment, and data-reporting capability. As medical-public health coordination, tiered diagnosis, and digital surveillance systems improve, infectious disease diagnostic testing will become a key node linking clinical treatment, hospital operations, and public health governance.
This report is a detailed and comprehensive analysis for global Infectious Disease Diagnostic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Infectious Disease Diagnostic Testing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Infectious Disease Diagnostic Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Infectious Disease Diagnostic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Infectious Disease Diagnostic Testing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infectious Disease Diagnostic Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infectious Disease Diagnostic Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Danaher, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Roche, DiaSorin, QuidelOrtho, Siemens Healthineers, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Infectious Disease Diagnostic Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Blood Sample
Respiratory Sample
Urine Sample
Other
Market segment by Technology
Molecular Diagnostics
Immunodiagnostics
Culture & AST
POCT Rapid Tests
Other
Market segment by Test Item
Respiratory Infections
Hepatitis & Blood-borne
Sexually Transmitted Infections
Gastrointestinal Infections
Other
Market segment by Application
Public Hospitals
Third-party Independent Laboratory
Other
Market segment by players, this report covers
BD
Danaher
Abbott
bioMérieux
Hologic
Thermo Fisher Scientific
Roche
DiaSorin
QuidelOrtho
Siemens Healthineers
Qiagen
Bio-Rad
Wondfo Biotech
Autobio
Daan Gene
Innovita
Hybribio
BioPerfectus
Sansure
Liferiver
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infectious Disease Diagnostic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Disease Diagnostic Testing, with revenue, gross margin, and global market share of Infectious Disease Diagnostic Testing from 2021 to 2026.
Chapter 3, the Infectious Disease Diagnostic Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Infectious Disease Diagnostic Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Disease Diagnostic Testing.
Chapter 13, to describe Infectious Disease Diagnostic Testing research findings and conclusion.

Buy now